v3.25.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Assets    
Debt securities, available for sale, at fair value, net of allowance for credit losses of $0.0 (2024 - $1.1) (cost - $4,700.0; 2024 - $5,143.8) $ 4,735.9 $ 5,131.0
Debt securities, trading, at fair value (cost - $125.1; 2024 - $187.3) 102.9 162.2
Short-term investments, at fair value (cost - $54.9; 2024 - $95.3) 54.9 95.8
Other long-term investments, at fair value (cost - $436.2; 2024 - $438.2) (includes related party investments at fair value of $218.1 (2024 - $217.2)) 320.1 316.5
Total investments 5,213.8 5,705.5
Cash and cash equivalents 732.4 682.0
Restricted cash and cash equivalents 190.8 212.6
Due from brokers 8.2 11.2
Interest and dividends receivable 42.5 44.0
Insurance and reinsurance balances receivable, net 2,290.1 2,054.4
Deferred acquisition costs, net 379.5 327.5
Unearned premiums ceded 484.0 463.9
Loss and loss adjustment expenses recoverable, net 2,263.9 2,315.3
Deferred tax asset 297.1 297.0
Intangible assets 135.1 140.8
Other assets 318.3 270.7
Total assets 12,355.7 12,524.9
Liabilities    
Loss and loss adjustment expense reserves 5,817.4 5,653.9
Unearned premium reserves 1,854.0 1,639.2
Reinsurance balances payable 1,539.9 1,781.6
Deferred gain on retroactive reinsurance 0.0 8.5
Debt 678.4 639.1
Due to brokers 9.0 18.0
Deferred tax liability 89.6 76.2
Share repurchase liability 0.0 483.0
Other liabilities 260.6 286.6
Total liabilities 10,248.9 10,586.1
Commitments and contingent liabilities
Shareholders’ equity    
Common shares (issued and outstanding: 116,759,539; 2024 - 116,429,057) 11.7 11.6
Additional paid-in capital 945.8 945.0
Retained earnings 901.7 784.9
Accumulated other comprehensive income (loss), net of tax 46.5 (4.1)
Shareholders’ equity attributable to SiriusPoint shareholders 2,105.7 1,937.4
Noncontrolling interests 1.1 1.4
Total shareholders’ equity 2,106.8 1,938.8
Total liabilities, noncontrolling interests and shareholders’ equity 12,355.7 12,524.9
Series B preference shares    
Shareholders’ equity    
Series B preference shares (par value $0.10; authorized and issued: 8,000,000) $ 200.0 $ 200.0